Timber Pharmaceuticals

+$0.012 (+1.71%) Today
-$0.0021 (-0.29%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TMBR and other ETFs, options, and stocks.

About TMBR

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma.

CEO
John Koconis
Employees
3
Headquarters
Basking Ridge, New Jersey
Founded
2019

TMBR Key Statistics

Market Cap
27.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
760.79K
High Today
$0.72
Low Today
$0.70
Open Price
$0.705
Volume
361.77K
52 Week High
$3.65
52 Week Low
$0.6651

TMBR Earnings

-$1.36
-$0.79
-$0.22
$0.35
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure